Phone
Email
Koligo Therapeutics
Manufacturing · Indiana, United States · <25 Employees
Who is Koligo Therapeutics
Koligo Therapeutics, Inc. is a US regenerative medicine company. Koligo's first commercial product is KYSLECEL® (autologous pancreatic islets) for chronic and acute recurrent pancreatitis. Koligo's 3D-V technology platform incorporates the use of advanced 3D bioprinting techniques and vascular endothelial cells to support development of transformational cell and tissue products for serious diseases.Read More
Headquarters:
2113 State St, New Albany, Indiana, 47150, United States
Phone Number:
(502) 265-4830
Revenue:
<$5 Million
Koligo Therapeutics's Social Media
Popular Searches:
Koligo Therapeutics Inc
Koligo Therapeutics
Koligo Therapeutics , Inc.
Legato Therapeutics Inc
Koligo Therapeutics - Inc
Koligo Therapeutics's Org Chart
PhoneEmail
Koligo Therapeutics's Tech Stack
Koligo Therapeutics News & Media
Orgenesis Completes Acquisition of Koligo Therapeutics and Announces Additional Acquisition of Icellator® Technology from Tissue Genesis in Related Transaction
Icellator® commercially available for lipotransfer in first two countries with more approvals expected Icellator® commercially available for lipotransfer in first two countries with more approvals expected
Oct 19, 2020Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL®, a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitisSep 29, 2020
Koligo Therapeutics to Participate in Maxim Group and M-Vest COVID-19 Virtual Conference Series on May 27, 2020
NEW ALBANY, INDIANA, UNITED STATES, May 22, 2020 /EINPresswire.com/ -- Koligo Therapeutics, Inc. (Koligo), a privately-held regenerative medicine company, today announced that Matthew Lehman, Chief Executive Officer, will be participating in the Maxim …May 22, 2020Subscribe to "Koligo Therapeutics" News
Frequently Asked Questions regarding Koligo Therapeutics
Where are Koligo Therapeutics’s headquarters?
Koligo Therapeutics’s headquarters are in 2113 State St, New Albany, Indiana, 47150, United States
What is Koligo Therapeutics’s phone number?
Koligo Therapeutics’s phone number is (502) 265-4830
What is Koligo Therapeutics’s official website?
Koligo Therapeutics’s official website is www.koligo.net
What is Koligo Therapeutics’s Revenue?
Koligo Therapeutics’s revenue is <$5 Million
What is Koligo Therapeutics’s SIC code?
Koligo Therapeutics’s SIC: 28,283
What is Koligo Therapeutics’s NAICS code?
Koligo Therapeutics’s NAICS: 3254,32541
How many employees are working in Koligo Therapeutics?
Koligo Therapeutics has <25 employees
What is Koligo Therapeutics’s industry?
Koligo Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What is Koligo Therapeutics's tech stack?
The technologies that are used by Koligo Therapeutics are: GoDaddy DNS, Google Cloud DNS, DigitalOcean, Office 365
Who is Koligo Therapeutics's CEO?
Koligo Therapeutics's CEO is Matthew Lehman
Who is Koligo Therapeutics's CTO?
Koligo Therapeutics's CTO is Stuart Williams
Slide to rate Matthew Lehman as a Chief Executive Officer
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
